FEB 25, 2025 Opens: 8:00 AM PST

Precision Oncology Showcase

The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is practiced worldwide. Taking place throughout 2025, this series will spotlight the transformative potential of the SOPHiA DDM™ Platform—our decentralized, AI-driven technology designed to unlock novel insights for improved cancer care.

Through engaging sessions led by thought leaders and renowned experts, attendees will explore how our partnerships, including collaborations with organizations like Memorial Sloan Kettering Cancer Center (MSK), are addressing critical healthcare challenges. Together, we are paving the way to reduce global disparities in access to precision oncology testing and delivering world-class analytics to institutions everywhere.

Join us in this journey as we showcase how our collective intelligence, powered by innovation and collaboration, is advancing the future of data-driven medicine.

Speakers

Michael Berger, Ph.D

Co-Director, Marie Josee & Henry Kravis Center for Molecular Oncology, MSKCC
BIOGRAPHY
Anita Bowman, M.S,

Associate Director of Clinical Bioinformatics, MSKCC
BIOGRAPHY

Webinars Share

Download Agenda

Tue Feb 25

FEB 25, 2025 8:00 AM PST

Clinical Genomics at MSK
Michael Berger, Ph.D

Co-Director, Marie Josee & Henry Kravis Center for Molecular Oncology, MSKCC
BIOGRAPHY
Dr. Berger’s session will explore the development of MSK-IMPACT and MSK-ACCESS, MSK’s comprehensive genomic profiling and cfDNA analysis programs. These initiatives address the need for large-scale molecular profiling across diverse tumor types. A key focus will be the role of matched tumor-normal sequencing in reducing biological false positives, ensuring true somatic variants are accurately identified while enabling seamless integration of germline analysis. Dr. Berger will also discuss how SOPHiA GENETICS has become a key collaborator, empowering MSK to expand the accessibility of precision oncology globally through scalable, cloud-based solutions.

Learning Objectives

Understand the evolution and unique features of MSK’s genomic profiling programs (MSK-IMPACT and MSK-ACCESS) and their role in advancing precision oncology.

Explore the critical benefits of matched tumor-normal sequencing in reducing biological false positives, enabling accurate somatic variant identification, and enhancing germline analysis.

Analyze real clinical cases demonstrating how MSK’s genomic technologies inform decision-making.
SEE ABSTRACT HIDE ABSTRACT | Continuing Education: P.A.C.E. CE
FEB 25, 2025 8:00 AM PST

Advancing Precision Oncology With a Matched Tumor-Normal Approach: Insights From the Clinic
Anita Bowman, M.S,

Associate Director of Clinical Bioinformatics, MSKCC
BIOGRAPHY
Anita Bowman will delve into the clinical applications of MSK-IMPACT and MSK-ACCESS at MSK, illustrating how these technologies meet the personalized needs of patients. Through real-world case studies, she will showcase how a matched tumor-normal approach has enhanced diagnosis and treatment planning. This methodology not only minimizes false positives but also identifies clonal hematopoiesis of indeterminate potential (CHIP) and resistance mechanisms, improving precision in treatment strategies.

Learning Objectives

Understand the evolution and unique features of MSK’s genomic profiling programs (MSK-IMPACT and MSK-ACCESS) and their role in advancing precision oncology.

Explore the critical benefits of matched tumor-normal sequencing in reducing biological false positives, enabling accurate somatic variant identification, and enhancing germline analysis.

Analyze real clinical cases demonstrating how MSK’s genomic technologies inform decision-making.
SEE ABSTRACT HIDE ABSTRACT | Continuing Education: P.A.C.E. CE

Speakers Share

Michael Berger, Ph.D

Co-Director, Marie Josee & Henry Kravis Center for Molecular Oncology, MSKCC

BIOGRAPHY
Anita Bowman, M.S,

Associate Director of Clinical Bioinformatics, MSKCC

BIOGRAPHY

Continuing Education Credits Share

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

FEB 25, 2025 8:00 AM PST

Clinical Genomics at MSK

Michael Berger, Ph.D

Co-Director, Marie Josee & Henry Kravis Center for Molecular Oncology, MSKCC

Presented at: Precision Oncology Showcase

P.A.C.E. CE
FEB 25, 2025 8:00 AM PST

Advancing Precision Oncology With a Matched Tumor-Normal...

Anita Bowman, M.S,

Associate Director of Clinical Bioinformatics, MSKCC

Presented at: Precision Oncology Showcase

P.A.C.E. CE

Help

Precision Oncology Showcase

Michael Berger, Ph.D

Anita Bowman, M.S,

Webinars Share // Get the id and entity for ajax statistics window.entity = 'VirtualEvent'; window.entityId = '9246';

Tue Feb 25

Clinical Genomics at MSK

Advancing Precision Oncology With a Matched Tumor-Normal Approach: Insights From the Clinic

Speakers Share // Get the id and entity for ajax statistics window.entity = 'VirtualEvent'; window.entityId = '9246';

Michael Berger, Ph.D

Anita Bowman, M.S,

Continuing Education Credits Share // Get the id and entity for ajax statistics window.entity = 'VirtualEvent'; window.entityId = '9246';

Clinical Genomics at MSK

Advancing Precision Oncology With a Matched Tumor-Normal...

LOGIN

Webinars Share

Speakers Share

Continuing Education Credits Share